Apothecary Capital

Apothecary Capital

Apothecary Capital

Xconomy

FibroGen Pushes Forward With Anemia Pill in China, But Big Test Awaits

Health Science
$62,000,000 Post-IPO equity
biospace

FibroGen Gets 62 Million License Payment from Partner AstraZeneca PLC

Health Science